相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perlecan Maintains Microvessel Integrity In Vivo and Modulates Their Formation In Vitro
Erika Gustafsson et al.
PLOS ONE (2013)
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Basel Sitohy et al.
CANCER RESEARCH (2012)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways TRANSCRIPTIONAL REPRESSION OF HYPOXIA-INDUCIBLE FACTOR 1α AND VEGFA AND CONCURRENT INHIBITION OF NUCLEAR FACTOR OF ACTIVATED T CELL 1 (NFAT1) ACTIVATION
Atul Goyal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation
Muneaki Ishijima et al.
MATRIX BIOLOGY (2012)
Perlecan-Deficient Mutation Impairs Corneal Epithelial Structure
Takenori Inomata et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Signal transduction by vascular endothelial growth factor receptors
Sina Koch et al.
BIOCHEMICAL JOURNAL (2011)
Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) A DUAL RECEPTOR ANTAGONISM
Atul Goyal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner
Liang Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and αvβ3 integrin
Niv Papo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stromal Endothelial Cells Directly Influence Cancer Progression
Joseph W. Franses et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Heparan Sulfate-Dependent Signaling of Fibroblast Growth Factor 18 by Chondrocyte-Derived Perlecan
Christine Y. Chuang et al.
BIOCHEMISTRY (2010)
Soluble perlecan domain i enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells
Arivalagan Muthusamy et al.
BMC BIOCHEMISTRY (2010)
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
Renato V. Iozzo et al.
FEBS JOURNAL (2010)
TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells
Seo-Jin Lee et al.
LABORATORY INVESTIGATION (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan
Martin D. Rees et al.
MATRIX BIOLOGY (2010)
A Key Role for the Integrin alpha 2 beta 1 in Experimental and Developmental Angiogenesis
James D. San Antonio et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity
Alexander Nystroem et al.
BLOOD (2009)
Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level
Xuefeng Zhang et al.
FASEB JOURNAL (2009)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis
Renato V. Iozzo et al.
MOLECULES AND CELLS (2009)
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Jason J. Zoeller et al.
MATRIX BIOLOGY (2009)
Diverse Cell Signaling Events Modulated by Perlecan
John M. Whitelock et al.
BIOCHEMISTRY (2008)
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-β signaling pathway
Aaron B. Baker et al.
CIRCULATION RESEARCH (2008)
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis
Guido Serini et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis
Jean-Francois Cailhier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A central function for perlecan in skeletal muscle and cardiovascular development
Jason J. Zoeller et al.
JOURNAL OF CELL BIOLOGY (2008)
Novel interactions of perlecan: Unraveling perlecan's role in angiogenesis
Gregory Bix et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2008)
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation
Angela Kadenhe-Chiweshe et al.
MOLECULAR CANCER RESEARCH (2008)
Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
Katherine Holmes et al.
CELLULAR SIGNALLING (2007)
Perlecan - a multifunctional extracellular proteoglycan scaffold
Mary C. Farach-Carson et al.
GLYCOBIOLOGY (2007)
Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1-integrin receptor
Gregory Bix et al.
BLOOD (2007)
Structure of a VEGF-VEGF receptor complex determined by electron microscopy
Claudia Ruch et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Endorepellin in vivo: Targeting the tumor vasculature and retarding cancer growth and metabolism
Gregory Bix et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Perlecan proteolysis induces an α2β1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation
Patrick Laplante et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation
Daniela G. Seidler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation
I Sher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells
DW Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Basement membrane proteoglycans: From cellar to ceiling
RV Iozzo
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Heparan sulfate: A complex polymer charged with biological activity
JM Whitelock et al.
CHEMICAL REVIEWS (2005)
BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan
EM Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
Y Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Matrix revolutions: 'tails' of basement-membrane components with angiostatic functions
G Bix et al.
TRENDS IN CELL BIOLOGY (2005)
Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin
G Bix et al.
JOURNAL OF CELL BIOLOGY (2004)
A novel interaction between perlecan protein core and progranulin - Potential effects on tumor growth
EM Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Angiogenesis in collagen I requires α2β1 ligation of a GFP* GER sequence and possibly p38 MAPK activation and focal adhesion disassembly
SM Sweeney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism
DW Seo et al.
CELL (2003)
Changes in perlecan expression during vascular injury - Role in the inhibition of smooth muscle cell proliferation in the late lesion
MG Kinsella et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
M Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1
YM Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice
M Costell et al.
CIRCULATION RESEARCH (2002)
The alpha(1)beta(1) and alpha(2)beta(1) Integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis
DR Senger et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
RV Iozzo et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes
Z Gluzman-Poltorak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Fibroblast growth factor-binding protein is a novel partner for perlecan protein core
M Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Perlecan heparan sulfate proteoglycan - A novel receptor that mediates a distinct pathway for ligand catabolism
IV Fuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia
MA Nugent et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7
M Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
